Evidence map›Paper›PMID 24491636›Full record

ReviewBioorganic & medicinal chemistry2014

Taccalonolide microtubule stabilizers.

Jing Li, April L Risinger, Susan L Mooberry

Open access · greenAbstract readReview
In one paragraph

Review in Bioorganic & medicinal chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Leveraging metabolic similarity in aScientific reports · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Resistance to anti-tubulin agents: From vinca alkaloids to epothilones.Cancer drug resistance (Alhambra, Calif.) · 2019
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. The Search for Anticancer Agents from Tropical Plants.Progress in the chemistry of organic natural products
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jing LiDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, TX 78229, United States; Cancer Therapy & Research Center, University of Texas Health Science Center at San Antonio, TX 78229, United States.
April L RisingerDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, TX 78229, United States; Cancer Therapy & Research Center, University of Texas Health Science Center at San Antonio, TX 78229, United States.
Susan L MooberryDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, TX 78229, United States; Department of Medicine, University of Texas Health Science Center at San Antonio, TX 78229, United States; Cancer Therapy & Research Center, University of Texas Health Science Center at San Antonio, TX 78229, United States. Electronic address: Mooberry@uthscsa.edu.
The University of Texas Health Science Center at San Antonio · US

Funding

Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
Institutional Research Training GrantT32DE014318 · NIDCR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Kenneth M Hargreaves · 2002 to 2026
$12.1M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthKL2TR001118 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, DOUGHERTY, DONALD M · 2013 to 2017
$3.4M
Taccalonolides: Mechanisms of Action and Cellular ResistanceR01CA121138 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MOOBERRY, SUSAN L · 2006 to 2016
$2.7M
NCATS NIH HHS KL2 TR001118NCATS NIH HHS UL1 TR001120NCI NIH HHS CA121138NCI NIH HHS R01 CA121138NIDCR NIH HHS DE 14318NIDCR NIH HHS T32 DE014318
6 · The paper itself

Abstract

This review focuses on a relatively new class of microtubule stabilizers, the taccalonolides. The taccalonolides are highly oxygenated pentacyclic steroids isolated from plants of the genus Tacca. Originally identified in a cell-based phenotypic screen, the taccalonolides have many properties similar to other microtubule stabilizers. They increase the density of interphase microtubules, causing microtubule bundling, and form abnormal multi-polar mitotic spindles leading to mitotic arrest and, ultimately, apoptosis. However, the taccalonolides differ from other microtubule stabilizers in that they retain efficacy in taxane resistant cell lines and in vivo models. Binding studies with the newly identified, potent taccalonolide AJ demonstrated covalent binding to β-tubulin at or near the luminal and/or pore taxane binding site(s) which stabilizes microtubule protofilaments in a unique manner as compared to other microtubule stabilizers. The isolation and semi-synthesis of 21 taccalonolides helped to identify key structure activity relationships and the importance of multiple regions across the taccalonolide skeleton for optimal biological potency.

Indexed as

Antineoplastic Agents, PhytogenicHumansMicrotubulesModels, MolecularMolecular ConformationSteroidsStructure-Activity RelationshipTubulin ModulatorsAntineoplastic Agents, PhytogenicSteroidstaccalonolide ATubulin ModulatorsLaulimalideMicrotubuleMicrotubule stabilizerPaclitaxelTaccaTaccalonolideTaxolTubulin

Identifiers

PMID24491636
PMCPMC4099425
OpenAlexW3177241550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.